Core Insights - UnitedHealth Group is a leading health insurance provider in the United States, competing with major players like Anthem and Cigna [1] Financial Performance - For the quarter ending October 28, 2025, UnitedHealth reported earnings per share (EPS) of $2.92, exceeding the estimated $2.80 and the Zacks Consensus Estimate of $2.75, resulting in an earnings surprise of 6.18%. However, this EPS decreased from $7.15 in the same quarter last year, indicating a decline in profitability [2] - The company's revenue for the quarter was $113.161 billion, slightly above the estimated $113.028 billion but falling short of the Zacks Consensus Estimate by 0.17%. This revenue reflects a significant increase from $100.82 billion reported a year ago, showcasing the company's growth efforts [3] Financial Metrics - UnitedHealth has a price-to-earnings (P/E) ratio of approximately 14.24, a price-to-sales ratio of about 0.76, and an enterprise value to sales ratio of around 0.71, indicating the market's valuation of its earnings and sales [4] - The current ratio is approximately 0.82, suggesting the company's ability to cover short-term liabilities with short-term assets. The earnings yield is about 7.02%, and the enterprise value to operating cash flow ratio is approximately 14.72, highlighting the company's cash flow efficiency [5]